sr141716 has been researched along with 6-cyano-7-nitroquinoxaline-2,3-dione in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Darmani, NA; Pandya, DK | 1 |
| Cunha, RA; Köfalvi, A; Ledent, C; Mackie, K; Rodrigues, RJ; Sperlágh, B; Vizi, ES | 1 |
| Fukaya, M; Kano, M; Kawamura, Y; Maejima, T; Miura, E; Ohno-Shosaku, T; Watanabe, M; Yoshida, T | 1 |
| Jean, A; Lebrun, B; Roux, J; Trouslard, J; Wanaverbecq, N | 1 |
| Deadwyler, SA; Hampson, RE; Miller, F; Palchik, G | 1 |
5 other study(ies) available for sr141716 and 6-cyano-7-nitroquinoxaline-2,3-dione
| Article | Year |
|---|---|
Involvement of other neurotransmitters in behaviors induced by the cannabinoid CB1 receptor antagonist SR 141716A in naive mice.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Alanine; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Dronabinol; Excitatory Amino Acid Antagonists; Fluorobenzenes; Glutamic Acid; Head Movements; Injections, Intraperitoneal; Male; Mice; Mice, Inbred ICR; Neurotransmitter Agents; Phenols; Piperidines; Psychotropic Drugs; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Serotonin; Serotonin Antagonists; Tachykinins | 2000 |
Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Benzoxazines; Blotting, Western; Calcium; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid; Glutamic Acid; Immunohistochemistry; Male; Mice; Mice, Knockout; Morpholines; Naphthalenes; Neurotransmitter Agents; Piperidines; Potassium; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Synapses; Synaptosomes; Tetrodotoxin; Tritium; Tyrosine 3-Monooxygenase; Vesicular Glutamate Transport Protein 1; Vesicular Glutamate Transport Protein 2 | 2005 |
The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Action Potentials; Animals; Benzoxazines; Cerebellar Cortex; Female; Hippocampus; Male; Membrane Potentials; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Immunoelectron; Morpholines; Naphthalenes; Patch-Clamp Techniques; Piperidines; Presynaptic Terminals; Purkinje Cells; Pyramidal Cells; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Species Specificity; Subcellular Fractions; Synaptic Membranes | 2006 |
Depolarization-induced release of endocannabinoids by murine dorsal motor nucleus of the vagus nerve neurons differentially regulates inhibitory and excitatory neurotransmission.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Arachidonic Acids; Benzoxazines; Brain Stem; Calcium Signaling; Cannabinoid Receptor Modulators; Capsaicin; Efferent Pathways; Endocannabinoids; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Glutamic Acid; Inhibitory Postsynaptic Potentials; Kynurenic Acid; Male; Mice; Mice, Inbred C57BL; Morpholines; Naphthalenes; Neurons; Piperidines; Pyrazoles; Pyridazines; Receptor, Cannabinoid, CB1; Receptors, Presynaptic; Rimonabant; Tetrodotoxin; Vagus Nerve | 2009 |
Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: implications for endocannabinoid control of hippocampal neural plasticity.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Arachidonic Acids; Benzamides; Benzoxazines; Calcium; Cannabinoid Receptor Modulators; Carbamates; Endocannabinoids; Glycine; Hippocampus; In Vitro Techniques; Morpholines; Naphthalenes; Neuronal Plasticity; Neurons; Phosphorylation; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptors, N-Methyl-D-Aspartate; Rimonabant; Ryanodine Receptor Calcium Release Channel; Second Messenger Systems | 2011 |